Breaking News Instant updates and real-time market news.

MLNX

Mellanox

$51.05

1 (2.00%)

, MRVL

Marvell

$21.59

1.3 (6.41%)

17:53
11/20/17
11/20
17:53
11/20/17
17:53

Starboard Value reports 9.8% stake in Mellanox, may seek talks

Peter A. Feld, a principal of Starboard Value LP, is a director of Marvell Technology Group (MRVL), which is a competitor in certain business lines of Mellanox (MLNX). In the past, Marvell has expressed an interest in discussing with Mellanox a potential strategic transaction on a negotiated friendly basis. Mellanox has declined to enter into any such discussions. To the knowledge of Starboard there are no current discussions regarding a strategic transaction between Marvell and Mellanox and Feld, while continuing to serve as a director of Marvell, has agreed that he would recuse himself from participation in any discussions at Marvell regarding any potential interest in Mellanox.

MLNX

Mellanox

$51.05

1 (2.00%)

MRVL

Marvell

$21.59

1.3 (6.41%)

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

  • 05

    Dec

  • 06

    Dec

MLNX Mellanox
$51.05

1 (2.00%)

10/26/17
JPMS
10/26/17
DOWNGRADE
Target $47
JPMS
Neutral
Mellanox downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Harlan Sur downgraded Mellanox Technologies to Neutral citing a "flattish" 2018 outlook for the Infiniband business and increasing competitive pressures in Ethernet. The analyst lowered his price target for the shares to $47 from $51 following Mellanox's Q3 results.
10/09/17
LEHM
10/09/17
DOWNGRADE
Target $48
LEHM
Underweight
Mellanox downgraded to Underweight from Overweight at Barclays
Barclays analyst Joseph Wolf double downgraded Mellanox (MLNX) to Underweight from Overweight following the stock's outperformance year-to-date. The company's lead in 40GBE is beginning to fade amid competition from Intel (INTC), Broadcom (BRCM), and Cavium (CAVM) while Amazon (AMZN) and Google (GOOG, GOOGL) are sourcing 25/50/100 internally, Wolf tells investors in a research note. The analyst recommends using the recent strength in shares of Mellanox to take profits as he sees other names in the group outperforming on a relative basis from here. He lowered his price target for the stock to $48 from $50.
08/29/17
BNCH
08/29/17
INITIATION
Target $60
BNCH
Buy
Mellanox initiated with a Buy at Benchmark (earlier)
Before the open, Benchmark analyst Gary Mobley started Mellanox with a Buy rating and $60 price target.
07/12/17
JEFF
07/12/17
NO CHANGE
Target $125
JEFF
Underperform
IBM price target lowered to $125 from $135 at Jefferies
Jefferies analyst James Kisner lowered his price target for IBM (IBM) to $125 and reiterates an Underperform rating on the shares. While channel checks indicate IBM's Watson platform remains one of the most complete cognitive platforms available in the marketplace today, the "hefty services" component of many artificial intelligence deployments will be a hindrance to adoption, Kisner tells investors in a research note titled "Creating Shareholder Value with AI? Not so Elementary, My Dear Watson." The analyst also believes IBM looks "outgunned in the war" for AI talent and will likely see increasing competition. Kisner adds that his firm believes Nvidia (NVDA) is the biggest beneficiary of ramping AI adoption. He lists Pure Storage (PSTG) and Mellanox (MLNX) as other beneficiaries.
MRVL Marvell
$21.59

1.3 (6.41%)

11/20/17
OPCO
11/20/17
NO CHANGE
Target $30
OPCO
Outperform
Marvell price target raised to $30 from $23 at Oppenheimer
Oppenheimer analyst Rick Schafer raised his price target for Marvell (MRVL) to $30 from $23 after the company announced plans to acquire Cavium (CAVM) in a 50/50 cash/stock transaction valuing the latter at about $84/share. The analyst believes that acquiring Cavium increases Marvell's exposure to the datacenter/networking markets, creating a robust portfolio to better compete against powerhouse Broadcom (AVGO). Schafer sees the deal as a strategic use of Marvell's $1.6B in cash, and says he is bullish on the combination. He reiterates an Outperform rating on Marvell's shares.
11/20/17
BNCH
11/20/17
UPGRADE
BNCH
Buy
Marvell upgraded to Buy from Hold at Benchmark
11/20/17
BOFA
11/20/17
UPGRADE
Target $26
BOFA
Buy
Marvell upgraded to Buy on Cavium deal at BofA/Merrill
BofA/Merrill analyst Vivek Arya upgraded Marvell (MRVL) two notches to Buy from Underperform and increased its price target to $26 from $15. The analyst said Marvell's proposed acquisition of Cavium (CAVM) adds secular growth drivers in cloud, 5G mobile networks, enterprise, and security with 25% potential earnings accretion. Arya views Cavium as an "ideal fit" for Marvell's slower growth profile and believes it better positions the company against larger peers.
11/20/17
BOFA
11/20/17
UPGRADE
BOFA
Buy
Marvell upgraded to Buy from Neutral at BofA/Merrill

TODAY'S FREE FLY STORIES

SRE

Sempra Energy

$115.78

0.54 (0.47%)

17:40
12/14/17
12/14
17:40
12/14/17
17:40
Hot Stocks
Sempra Energy, Oncor announce settlement with key stakeholders »

Oncor Electric Delivery…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$50.19

0.14 (0.28%)

17:40
12/14/17
12/14
17:40
12/14/17
17:40
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle says FY18 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ORCL

Oracle

$50.19

0.14 (0.28%)

, AMZN

Amazon.com

$1,174.26

10.13 (0.87%)

17:34
12/14/17
12/14
17:34
12/14/17
17:34
Hot Stocks
Breaking Hot Stocks news story on Oracle, Amazon.com »

Oracle says switching…

ORCL

Oracle

$50.19

0.14 (0.28%)

AMZN

Amazon.com

$1,174.26

10.13 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Mar

EPD

Enterprise Products

$26.07

0.17 (0.66%)

17:33
12/14/17
12/14
17:33
12/14/17
17:33
Hot Stocks
Enterprise Products to implement further oil quality specifications at Cushing »

Enterprise Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$175.00

-1.83 (-1.03%)

17:31
12/14/17
12/14
17:31
12/14/17
17:31
Hot Stocks
Adobe 'pleased' with subscription bookings and advertising cloud »

Says photography offering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

JBL

Jabil Circuit

$27.45

-1.08 (-3.79%)

, COST

Costco

$186.53

-1.75 (-0.93%)

17:30
12/14/17
12/14
17:30
12/14/17
17:30
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Jabil…

JBL

Jabil Circuit

$27.45

-1.08 (-3.79%)

COST

Costco

$186.53

-1.75 (-0.93%)

CNC

Centene

$99.02

-2.17 (-2.14%)

DCIX

Diana Containerships

$4.87

-0.37 (-7.06%)

MS

Morgan Stanley

$52.64

-0.54 (-1.02%)

DDR

DDR Corp.

$7.96

-0.11 (-1.36%)

RMBL

RumbleON

$5.30

-0.06 (-1.12%)

SAH

Sonic Automotive

$20.05

-0.95 (-4.52%)

HES

Hess Corp.

$42.67

-1.43 (-3.24%)

FORM

FormFactor

$14.90

-0.05 (-0.33%)

ORCL

Oracle

$50.19

0.14 (0.28%)

VSTM

Verastem

$3.65

-0.15 (-3.95%)

GBT

Global Blood Therapeutics

$39.40

1.05 (2.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

  • 09

    Jan

AEP

American Electric

$76.29

-0.22 (-0.29%)

17:28
12/14/17
12/14
17:28
12/14/17
17:28
Syndicate
Breaking Syndicate news story on American Electric »

American Electric files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$158.03

-6.62 (-4.02%)

17:25
12/14/17
12/14
17:25
12/14/17
17:25
Conference/Events
Sage Therapeutics management to meet with RBC Capital »

Dinner Meeting will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

ORCL

Oracle

$50.20

0.14 (0.28%)

17:24
12/14/17
12/14
17:24
12/14/17
17:24
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle CEO Hurd says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ADBE

Adobe

$175.00

-1.83 (-1.03%)

17:23
12/14/17
12/14
17:23
12/14/17
17:23
Hot Stocks
Adobe targeting subscription bookings growth of 20% in FY18 »

Says expect quarterly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ADBE

Adobe

$175.00

-1.83 (-1.03%)

17:20
12/14/17
12/14
17:20
12/14/17
17:20
Hot Stocks
Adobe says advertising cloud had a 'strong' year »

Says advertising cloud…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ORCL

Oracle

$50.19

0.14 (0.28%)

17:20
12/14/17
12/14
17:20
12/14/17
17:20
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle says currency…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ORCL

Oracle

$50.19

0.14 (0.28%)

17:19
12/14/17
12/14
17:19
12/14/17
17:19
Earnings
Oracle sees Q3 adjusted EPS 68c-70c, consensus 72c »

Sees Q3 revenue growth of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

UBA

Urstadt Biddle

$22.71

-0.48 (-2.07%)

, UBP

Urstadt Biddle Properties Inc.

$18.00

-0.01 (-0.06%)

17:17
12/14/17
12/14
17:17
12/14/17
17:17
Hot Stocks
Urstadt Biddle raises quarterly dividend by 0.5c to 27c »

At their regular meeting…

UBA

Urstadt Biddle

$22.71

-0.48 (-2.07%)

UBP

Urstadt Biddle Properties Inc.

$18.00

-0.01 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$50.19

0.14 (0.28%)

17:14
12/14/17
12/14
17:14
12/14/17
17:14
Hot Stocks
Oracle says customer adoption of cloud products 'remains very strong' »

Says expects to continue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

NQ

NQ Mobile

$4.13

0.02 (0.49%)

17:14
12/14/17
12/14
17:14
12/14/17
17:14
Hot Stocks
NQ Mobile announces partnership with Chery Automotive »

NQ Mobile Inc announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

CVX

Chevron

$119.53

-0.4 (-0.33%)

, SLB

Schlumberger

$62.37

-0.93 (-1.47%)

17:12
12/14/17
12/14
17:12
12/14/17
17:12
Periodicals
Chevron near pact with Schlumberger to drill six Brazil wells, Reuters says »

Chevron (CVX) has reached…

CVX

Chevron

$119.53

-0.4 (-0.33%)

SLB

Schlumberger

$62.37

-0.93 (-1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

VSTM

Verastem

$3.65

-0.15 (-3.95%)

17:07
12/14/17
12/14
17:07
12/14/17
17:07
Syndicate
Verastem files to sell $25M of common stock »

BTIG is acting as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNR

Denbury Resources

$1.62

0.02 (1.25%)

17:06
12/14/17
12/14
17:06
12/14/17
17:06
Syndicate
Breaking Syndicate news story on Denbury Resources »

Denbury Resources files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCBS

Nicolet Bankshares

$56.52

-1.12 (-1.94%)

17:05
12/14/17
12/14
17:05
12/14/17
17:05
Initiation
Nicolet Bankshares initiated  »

Nicolet Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GALE

Galena

$0.32

0.0399 (14.24%)

17:05
12/14/17
12/14
17:05
12/14/17
17:05
Hot Stocks
Galena to adjourn special meeting until Friday, December 29 »

Galena Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDS

FactSet

$202.46

0.44 (0.22%)

17:04
12/14/17
12/14
17:04
12/14/17
17:04
Initiation
FactSet initiated  »

FactSet initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

UTX

United Technologies

$123.76

-0.54 (-0.43%)

17:04
12/14/17
12/14
17:04
12/14/17
17:04
Hot Stocks
United Technologies awarded $6.7B U.S. Air Force contract »

United Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNPR

Juniper

$28.80

-0.31 (-1.06%)

17:03
12/14/17
12/14
17:03
12/14/17
17:03
Initiation
Juniper initiated  »

Juniper resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$37.90

-0.25 (-0.66%)

17:03
12/14/17
12/14
17:03
12/14/17
17:03
Initiation
Cisco initiated  »

Cisco resumed with a Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.